M0249Medical Services

Intravenous infusion, tocilizumab, for hospitalized adults and pediatric

Short description: Adm tocilizu covid-19 1st

Effective date: June 24, 2021
Termination date: —

Related codes (M-series)

M0001Advancing cancer care mvp M0002Opt care kidney hlth mvp M0003Opt care episod neuro mvp M0004Qual care neurologic cnd mvp M0005Value in primary care mvp M0010Eom meos payment M0064Visit for drug monitoring M0075Cellular therapy M0076Prolotherapy M0100Intragastric hypothermia M0201Pne flu hepb cov home admin M0220Tixagev and cilgav inj

Frequently asked questions

What is HCPCS code M0249?

M0249 is a HCPCS Level II code for Intravenous infusion, tocilizumab, for hospitalized adults and pediatric.

What category is HCPCS code M0249 in?

M0249 falls under the Medical Services category of HCPCS Level II.

When did HCPCS code M0249 become effective?

M0249 has been effective since June 24, 2021, per CMS's quarterly HCPCS update.

HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.